Related Experiment Video

Updated: Jan 28, 2026

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
06:55

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Published on: October 26, 2016

9.4K

Contemporary Management of Stent Failure: Part One

Nikhil Pal1, Jehangir Din1, Peter O'Kane1

  • 1Dorset Heart Centre, Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth, UK.

Interventional Cardiology (London, England)
|March 13, 2019
PubMed

Insights

In-stent restenosis (ISR) remains a challenge despite technological advances. This review details ISR mechanisms, diagnostics, and management strategies for improved patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • In-stent restenosis (ISR) is a significant complication following coronary interventions.
  • Despite advancements in stent technology, ISR continues to pose a clinical challenge.
  • Understanding ISR pathophysiology is crucial for effective management.

Purpose of the Study:

  • To comprehensively review the pathophysiology and mechanisms of ISR.
  • To discuss diagnostic tools for elucidating ISR.
  • To propose a management algorithm and outline contemporary treatment strategies for ISR.

Main Methods:

  • Literature review of ISR pathophysiology and mechanisms.
  • Analysis of diagnostic modalities for ISR detection.
  • Synthesis of current treatment strategies and technologies for ISR management.

Main Results:

  • Detailed exploration of the biological processes leading to ISR.
  • Evaluation of various imaging and functional tests for ISR diagnosis.
  • Presentation of a simplified algorithm for ISR management, considering treatment options.

Conclusions:

  • ISR requires a thorough understanding of its complex mechanisms.
  • Appropriate diagnostic tools are essential for accurate ISR assessment.
  • Evidence-based management strategies and contemporary technologies can optimize patient outcomes in ISR.

Keywords:
Coronary heart diseasebare metal stentdrug-eluting stentin-stent restenosisstent failure

More Related Videos

Experimental Investigation of Secondary Flow Structures Downstream of a Model Type IV Stent Failure in a 180° Curved Artery Test Section11:00

Experimental Investigation of Secondary Flow Structures Downstream of a Model Type IV Stent Failure in a 180° Curved Artery Test Section

Published on: July 19, 2016

12.0K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.1K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
267
Contemporary Psychology01:29

Contemporary Psychology

Psychology explores human behavior and mental processes through various lenses, each offering unique insights. This overview examines key subfields, including biopsychology, evolutionary, developmental, personality, and social psychology, highlighting their approaches and contributions to understanding complex human behaviors.
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
2.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
968
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K